Previous 10 | Next 10 |
From Nov. 9-11, 2023, hundreds of speakers and exhibitors as well as thousands of attendees congregated at Ice Palace Film Studios to discuss the applications of psychedelics during Wonderland Miami 2023. Unlike last year’s iteration of the conference, which focused on the hallmarks of...
2023-11-20 17:34:17 ET Symbotic ( SYM ) +20% . Veradigm ( MDRX ) +6% . Tactile Systems Technology ( TCMD ) +6% . Farmer Brothers Company ( FARM ) +4% . Outset Medical ( OM ) +4% . MorphoSys ( MOR ) -32% ...
In the recent years, we’ve seen more studies explore the therapeutic benefits of psychedelics, with researchers as well as public figures such as Prince Harry discussing the mental and physical health benefits of these substances. Some countries have even relaxed their laws on psychede...
A campaign that was working to legalize psychedelics in California has suspended its efforts to get a psychedelic legalization initiative on the 2024 ballot. Treat California is a citizen-driven ballot measure that would have funded the research and development of psychedelic medicines in Cal...
2023-11-02 20:39:04 ET Mind Medicine (MindMed) Inc. (MNMD) Q3 2023 Results Conference Call November 02, 2023 04:30 PM ET Company Participants Rob Barrow - Chief Executive Officer Schond Greenway - Chief Financial Officer Dr. Dan Karlin - Chief Medical Officer ...
– Topline readout of MM-120 in GAD (Phase 2b) expected in Q4 2023 – – Topline readout of MM-120 in ADHD (Phase 2a proof-of-concept) anticipated by the end of Q1 2024 – – MM-402 in ASD on track for Phase 1 clinical trial initiation in Q4 2023 – ...
Supporters of a campaign to legalize psychedelics in Massachusetts believe they have gathered enough signatures to compel legislators to consider their initiative. If this is not successful, the group plans to put the psychedelics legalization measure on next year’s ballot. This move c...
Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...
Mind Medicine (MindMed) Inc. (MNMD) is expected to report $-0.65 for Q3 2023
A recent Canadian study has suggested that psilocybin, the main hallucinogenic agent in magic mushrooms, may ease the psychological distress associated with childhood trauma. Researchers say the psychedelic seemed to offer “particularly strong benefits” to individuals who faced ex...
News, Short Squeeze, Breakout and More Instantly...
Mind Medicine (MindMed) Inc. Company Name:
MNMD Stock Symbol:
NASDAQ Market:
Mind Medicine (MindMed) Inc. Website:
- New patent covers MM120 ODT formulation and extends patent term to 2041- - Claims include pharmaceutical formulation, methods of manufacturing and methods of treatment for MM120 ODT- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed...
Cluster headaches are headaches characterized by severe pain that often occurs on a side of the head or behind one eye. These headaches may last anywhere between 15 minutes to 3 hours and usually strike suddenly, often recurring more than once a day. The pain experienced by patients is... R...